● Recruiting

A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio 1453P in Healthy Adults

Condition: Healthy Participants · Sponsor: Debiopharm International SA

PhasePhase 1

Planned participants88

Who can joinAll sexes, 18 Years to 55 Years

Healthy volunteersYes

About this study

The main purpose of this study is to evaluate the safety, tolerability and pharmacokinetics (PK) of Debio 1453P compared to placebo across different dose levels in healthy adults after single and repeated oral dosing.

This description comes directly from the study's public registry record.

Talk to the study team

Debiopharm International S.A · +41213210111 · clinicaltrials@debiopharm.com

Always discuss trial participation with your own doctor first.

Locations (1)

SGS Belgium NV - Clinical Pharmacology Unit

Edegem, Belgium

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07035769